Rare diseases
Investigational molecules
Locations
Back to Germany19 clinical trials in Bramsche, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study on the Effects of JNJ-81241459 for Patients with Moderate to Severe Psoriasis
GermanyJNJ-95597528 for Adults with Moderate to Severe Atopic Dermatitis
GermanyStudy on the Safety and Immune Response of a Booster Dose of MenACYW Conjugate Vaccine in Children and Adolescents Previously Vaccinated for Meningococcal Infection
GermanyStudy on the Safety and Immune Response of MenABCWY Vaccine in Healthy Adolescents Aged 11-14 with Meningococcal Meningitis
GermanyStudy of remibrutinib for long-term treatment of adult patients with chronic spontaneous urticaria who completed previous remibrutinib studies
GermanyStudy on Dose Flexibility of Upadacitinib for Adults with Moderate to Severe Atopic Dermatitis
GermanyStudy on the Effectiveness and Safety of HRO350 for Patients with Mild-to-Moderate Psoriasis
GermanyThe busiest research cities in the country
What the registry says about research in the country
Research focusing on meningococcal vaccines and their long-term effectiveness, including studies on booster doses for children and adolescents.
Multiple trials evaluating new quadrivalent vaccines and their safety profiles across different age groups.
Comprehensive research into treatments for moderate to severe plaque psoriasis and atopic dermatitis, testing novel therapeutic approaches.
Several trials exploring new medications with different dosing regimens and their comparative effectiveness.
Innovative research addressing chronic spontaneous urticaria and hidradenitis suppurativa, focusing on breakthrough treatments.
Studies evaluating both established and experimental therapies for persistent skin conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
